1. 1. White GC II, Marder VJ, Colman RW, et al. Approach to the bleeding patient. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 3rd ed. Philadelphia, PA: Lippincott; 1994: 1134-1147.
2. 2. Feinstein DI. Immune coagulation disorders. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Pracice. 3rd ed. Philadelphia, PA Lippincott; 1994; 881-905.
3. 3. McKenna R, Bachmann F, Miro-Quesada M. Thrombo¬embolism in patients with abnormally short activated thromboplastin time. ThrombHaemost. 1977; 38: 893-899.
4. Venous thromboembolism in acute stroke: prognostic importance of hypercoagulability;Landi;Arch Neurol,1992
5. Extremely shortened activated partial thromboplastin times [letter];Belliveau;JAMA,1980